Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
83°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
November 21, 2021
Tickers
CRSP
NTLA
Tags
CRSP
Market News
NTLA
From
Motley Fool
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
NVO
Market News
VRTX
From
Benzinga
Intellia Therapeutics, Inc (NTLA) Q3 2021 Earnings Call Transcript
November 06, 2021
Tickers
NTLA
Tags
Market News
NTLA
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
GH
PBYI
DRNA
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
RAPT
RGNX
FULC
From
Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
Tickers
CRSP
NTLA
REGN
VRTX
Tags
Market News
CRSP
NTLA
From
Motley Fool
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
Tickers
ARKG
BEAM
DIS
EXAS
Tags
ARKG
BEAM
NTLA
From
Motley Fool
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
NASDAQ:EDIT,NASDAQ:NTLA
EDIT
Hot Stocks
From
InvestorPlace
EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock
October 18, 2021
Tickers
NTLA
Tags
Benzinga
NTLA
David Lebwohl
From
Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
Tickers
ARKG
ARKK
BEAM
CRSP
Tags
CRSP
Market News
ARKG
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
NTLA
BEAM
ALLO
From
Motley Fool
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
October 15, 2021
Tickers
BLFS
EDIT
LZAGF
MRNA
Tags
BLFS
MRNA
EDIT
From
Motley Fool
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
Tickers
ALNY
CELH
GOOG
GOOGL
Tags
VIR
GOOG
Market News
From
Motley Fool
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
Tickers
ATRA
CRSP
CTSO
FIXX
Tags
Offerings
Market News
Small Cap
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
Tickers
CRSP
MRK
NTLA
REGN
Tags
Market News
MRK
CRSP
From
Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Tickers
AGRX
ALLO
CCXI
CLLS
Tags
NTLA
VYGR
ALLO
From
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Tickers
ABIO
ADVM
AFIB
AGRX
Tags
AGRX
MBRX
TPTX
From
Benzinga
3 Spooky Healthcare Stocks I Would Avoid in October
October 07, 2021
Tickers
BKD
EDIT
JNJ
MRNA
Tags
JNJ
Market News
NTLA
From
Motley Fool
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
October 06, 2021
Tickers
NTLA
Tags
General
Phase 1 Trial
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Tickers
AC
ACA
ACI
ADDYY
Tags
SAIL
SHOO
DECK
From
Benzinga
3 Most Overvalued Biotech Stocks on the Market Right Now
October 01, 2021
Tickers
BEAM
BNTX
CRSP
CVAC
Tags
CVAC
NTLA
BEAM
From
Motley Fool
Why Shares of Editas Medicine Are Lower This Morning
September 29, 2021
Tickers
EDIT
NTLA
REGN
Tags
NTLA
EDIT
REGN
From
Motley Fool
Breaking Down CRISPR Technology
September 28, 2021
Tickers
BEAM
CRBU
CRSP
EDIT
Tags
VRTX
Market News
CRSP
From
Motley Fool
Where Intellia Therapeutics Stands With Analysts
September 24, 2021
Tickers
NTLA
Tags
Benzinga
NTLA
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
Tickers
ACHC
AEM
ALLO
ALV
Tags
VLY
Downgrades
ROKU
From
Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
Tickers
ARKG
ARKK
BEAM
CLLS
Tags
ARKK
NTLA
CRBU
From
Motley Fool
3 Moonshot Stocks Hidden in Cathie Wood’s Portfolios
September 22, 2021
Tickers
AMZN
ARKK
CNDT
COIN
Tags
SRAD
RBLX
ARKK
From
InvestorPlace
Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
September 16, 2021
Tickers
NTLA
Tags
Biotech
Phase 1 Trial
cancer
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
Tickers
ACER
ACRS
AERI
CRVS
Tags
Top Gainers
BZI/TFM
SBTX
From
Benzinga
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
Tickers
BAC
BEAM
BLUE
CLLS
Tags
REGN
Hot Stocks
NTLA
From
InvestorPlace
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.